tailieunhanh - Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

Treatment for non-small cell lung cancer (NSCLC) has greatly improved in recent years. However, noninvasive early screening for carcinogenesis and progression unclear. The aim of this study was to explore the predictive value of peripheral blood immune cells in untreated NSCLC patients. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN